NCT05231772View on ClinicalTrials.gov

Probiotics and Hemodynamic Changes in Cirrhosis

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

March 29, 2022

Study Completion Date

March 29, 2022

Conditions
Cirrhosis
Interventions
DRUG

Saccharomyces Boulardii Probiotic Supplement

Probiotic yeast

DRUG

Placebo

Placebo

Trial Locations (1)

119435

Clinic for Internal Diseases, Gastroenterology and Hepatology at Sechenov University, Moscow

All Listed Sponsors
lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT05231772 - Probiotics and Hemodynamic Changes in Cirrhosis | Biotech Hunter | Biotech Hunter